How much does Larotrectinib treatment cost approximately? Is it covered by medical insurance?
Larotrectinib is a targeted drug specifically designed to treat patients with solid tumors carrying NTRK gene fusions. Its biggest feature is "broad-spectrum anti-cancer". No matter which organ the tumor originates from, as long as there is an NTRK fusion mutation, it is possible to benefit from it. With its official launch in China, larotrectinib has also been included in the national medical insurance directory, which has greatly alleviated the financial pressure on patients.
At present, larotrectinib used in China is mainly the original version of the drug, produced by Bayer. The price is relatively high, and the market retail price is about 20,000 yuan. However, under the coverage of medical insurance reimbursement policies, the actual patient out-of-pocket ratio has dropped significantly. The specific reimbursement ratio and payment method vary by region. It is recommended that patients go to the top tertiary hospitals or medical insurance designated pharmacies in their region for detailed consultation to obtain personalized reimbursement plans.
For patients who are not covered by medical insurance or have limited out-of-pocket ability, overseas generic drug channels can also be considered. In the Laotian market, generic versions of larotrectinib have been launched, such as those produced by pharmaceutical companies such as Lucius. The prices range from only a few hundred yuan to more than 1,000 yuan, which is significantly lower than the original drug. Although generic drugs are not certified by the China Food and Drug Administration, they are consistent with the original drugs in terms of ingredients and dosage, making them an important choice for some patients with limited financial resources.
Taken together, larotinib, as a highly precise targeted drug, has significant efficacy, but the price of the original drug is relatively high. The good news is that domestic medical insurance already covers this drug, greatly improving its accessibility. Before taking medication, patients should reasonably choose original drugs or generic drugs based on their own financial situation, medical insurance policy and doctor's advice, and maintain close communication with the attending doctor during treatment to ensure treatment effects and medication safety.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)